Regulation 44ZL Post-market surveillance reportF1
Subject to paragraph (4), the manufacturer must produce a post-market surveillance report (“PMSR”) for the following—
a device placed on the market in accordance with regulation 19B and classified as belonging to class I under Directive 93/42;
a device placed on the market in accordance with regulation 19C and classified as belonging to class I under Regulation (EU) 2017/745;
a device otherwise placed on the market or put into service in accordance with Part 2 and classified as belonging to class I under regulation 7 (classification of general medical devices);
a device placed on the market in accordance with regulation 44ZB and classified as belonging to class A or B under Regulation (EU) 2017/746;
a device otherwise placed on the market or put into service in accordance with Part 4 that is not a device referred to in the lists in Annex II of Directive 98/79.
The PMSR must include—
a summary of the results and conclusions of the analyses of the information collected as a result of the post-market surveillance plan, and
a description of any preventive or corrective action that has been taken by the manufacturer in relation to the device and the reason for doing so.
A PMSR must be—
produced within 3 years of the device being placed on the market or put into service, whichever is sooner, and
updated by the manufacturer at least every 3 years until the end of the PMS period for the device model.
This regulation shall not apply to a relevant device which is a system or procedure pack, unless–
the system or procedure pack incorporates a medical device which does not bear a UKCA marking or a CE marking; or
the chosen combination of medical devices is not compatible in view of their original intended use.
In paragraph (2)(b) the reference to “any preventive or corrective action” includes any action taken before the device was placed on the market or put into service if—
for devices with a certificate that was issued by an approved body or notified body before the declaration of conformity was drawn up, the action was taken after that certificate was issued;
for any other devices, the action was taken after the declaration of conformity was drawn up.
Annotations
Textual amendments
- F1
Pt. 4A inserted (E.W.S.) (17.6.2025) by The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 (S.I. 2024/1368), regs. 1(2), 4